Boehringer Ingelheim’s Strategic Move in Pet Health

Boehringer Ingelheim Acquires Saiba Animal Health

Boehringer Ingelheim, a leading biopharmaceutical company, has made a strategic acquisition of Saiba Animal Health AG to bolster its research and development (R&D) in the pet therapeutics sector. This move is inspired by the rapid growth within the pet health industry and the increasing need for innovative treatments for chronic diseases in pets as their life expectancy rises.